Compare CAE & ICLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CAE | ICLR |
|---|---|---|
| Founded | 1947 | 1990 |
| Country | Canada | Ireland |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Commercial Physical & Biological Resarch |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.1B | 9.3B |
| IPO Year | 2002 | 2001 |
| Metric | CAE | ICLR |
|---|---|---|
| Price | $25.30 | $146.18 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 3 | 13 |
| Target Price | $33.33 | ★ $178.62 |
| AVG Volume (30 Days) | 898.5K | ★ 1.1M |
| Earning Date | 05-29-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $4.97 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $35.13 | ★ $12.91 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $22.76 | $66.57 |
| 52 Week High | $34.24 | $211.00 |
| Indicator | CAE | ICLR |
|---|---|---|
| Relative Strength Index (RSI) | 47.52 | 63.32 |
| Support Level | $25.29 | $99.11 |
| Resistance Level | $26.08 | $188.03 |
| Average True Range (ATR) | 0.78 | 8.29 |
| MACD | 0.06 | 1.04 |
| Stochastic Oscillator | 72.59 | 77.73 |
CAE Inc provides training and aviation services, integrated enterprise solutions, in-service support, and crew-sourcing services. The company operations are managed through two segments: Civil Aviation which offers comprehensive training solutions for flight, cabin, maintenance, and ground personnel in commercial, business, and helicopter aviation, a complete range of flight simulation training devices, ab initio pilot training, and crew sourcing services, as well as aircraft flight operations solutions; and Defense and Security which is a world-wide training and simulation provider delivering scalable, platform-independent solutions that enable and enhance force readiness and security. It generates the majority of its revenue from the Civil Aviation segment.
Icon is a global contract research organization that provides outsourced clinical development services to pharmaceutical and biotechnology firms. Icon supports clients across late-stage clinical trials through the regulatory approval process and postmarket studies. Icon's services include clinical trial management, patient recruitment, data analytics, laboratory services, and regulatory consulting. With more than 40,000 employees operating in over 50 countries, the company partners with life sciences firms to run clinical trials and bring new drugs to market.